Comment on: Jones et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study) - Sonmez, A; Taslipinar, A; Tapan, S; Serdar, M A (Diabetes Care, 2011)
Diabetes Care 2011; 34: e172